PMC:7443692 / 1157-1483 JSONTXT

{"project":"LitCovid-sample-PD-NCBITaxon","denotations":[{"id":"T6","span":{"begin":159,"end":169},"obj":"Species"},{"id":"T7","span":{"begin":223,"end":228},"obj":"Species"}],"attributes":[{"id":"A6","pred":"ncbi_taxonomy_id","subj":"T6","obj":"NCBItxid:2697049"},{"id":"A7","pred":"ncbi_taxonomy_id","subj":"T7","obj":"NCBItxid:9606"}],"namespaces":[{"prefix":"NCBItxid","uri":"http://purl.bioontology.org/ontology/NCBITAXON/"}],"text":"form therapeutic strategies to inhibit viral infection.\n\nGraphical Abstract\n\nHighlights\n• Site-specific N-linked microheterogeneity is defined at 22 sites of SARS-CoV-2 Spike\n• Six sites of N-linked microheterogeneity of human ACE2 receptor are described\n• Molecular dynamics simulations of Spike and ACE2 show essential ro"}

{"project":"LitCovid-sample-sentences","denotations":[{"id":"T9","span":{"begin":57,"end":75},"obj":"Sentence"},{"id":"T10","span":{"begin":77,"end":87},"obj":"Sentence"},{"id":"T11","span":{"begin":88,"end":175},"obj":"Sentence"},{"id":"T12","span":{"begin":176,"end":256},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"form therapeutic strategies to inhibit viral infection.\n\nGraphical Abstract\n\nHighlights\n• Site-specific N-linked microheterogeneity is defined at 22 sites of SARS-CoV-2 Spike\n• Six sites of N-linked microheterogeneity of human ACE2 receptor are described\n• Molecular dynamics simulations of Spike and ACE2 show essential ro"}

{"project":"LitCovid-sample-PD-MONDO","denotations":[{"id":"T3","span":{"begin":39,"end":54},"obj":"Disease"},{"id":"T4","span":{"begin":159,"end":169},"obj":"Disease"}],"attributes":[{"id":"A3","pred":"mondo_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/MONDO_0005108"},{"id":"A4","pred":"mondo_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"form therapeutic strategies to inhibit viral infection.\n\nGraphical Abstract\n\nHighlights\n• Site-specific N-linked microheterogeneity is defined at 22 sites of SARS-CoV-2 Spike\n• Six sites of N-linked microheterogeneity of human ACE2 receptor are described\n• Molecular dynamics simulations of Spike and ACE2 show essential ro"}

{"project":"LitCovid-sample-UniProt","denotations":[{"id":"T277","span":{"begin":229,"end":233},"obj":"Protein"},{"id":"T278","span":{"begin":304,"end":308},"obj":"Protein"}],"attributes":[{"id":"A277","pred":"uniprot_id","subj":"T277","obj":"https://www.uniprot.org/uniprot/Q9UFZ6"},{"id":"A278","pred":"uniprot_id","subj":"T278","obj":"https://www.uniprot.org/uniprot/Q9UFZ6"}],"text":"form therapeutic strategies to inhibit viral infection.\n\nGraphical Abstract\n\nHighlights\n• Site-specific N-linked microheterogeneity is defined at 22 sites of SARS-CoV-2 Spike\n• Six sites of N-linked microheterogeneity of human ACE2 receptor are described\n• Molecular dynamics simulations of Spike and ACE2 show essential ro"}

{"project":"LitCovid-sample-PD-IDO","denotations":[{"id":"T6","span":{"begin":45,"end":54},"obj":"http://purl.obolibrary.org/obo/IDO_0000586"},{"id":"T7","span":{"begin":91,"end":95},"obj":"http://purl.obolibrary.org/obo/BFO_0000029"},{"id":"T8","span":{"begin":150,"end":155},"obj":"http://purl.obolibrary.org/obo/BFO_0000029"},{"id":"T9","span":{"begin":183,"end":188},"obj":"http://purl.obolibrary.org/obo/BFO_0000029"}],"text":"form therapeutic strategies to inhibit viral infection.\n\nGraphical Abstract\n\nHighlights\n• Site-specific N-linked microheterogeneity is defined at 22 sites of SARS-CoV-2 Spike\n• Six sites of N-linked microheterogeneity of human ACE2 receptor are described\n• Molecular dynamics simulations of Spike and ACE2 show essential ro"}

{"project":"LitCovid-sample-PD-GO-BP-0","denotations":[{"id":"T4","span":{"begin":39,"end":54},"obj":"http://purl.obolibrary.org/obo/GO_0016032"}],"text":"form therapeutic strategies to inhibit viral infection.\n\nGraphical Abstract\n\nHighlights\n• Site-specific N-linked microheterogeneity is defined at 22 sites of SARS-CoV-2 Spike\n• Six sites of N-linked microheterogeneity of human ACE2 receptor are described\n• Molecular dynamics simulations of Spike and ACE2 show essential ro"}

{"project":"LitCovid-sample-GO-BP","denotations":[{"id":"T4","span":{"begin":39,"end":54},"obj":"http://purl.obolibrary.org/obo/GO_0016032"}],"text":"form therapeutic strategies to inhibit viral infection.\n\nGraphical Abstract\n\nHighlights\n• Site-specific N-linked microheterogeneity is defined at 22 sites of SARS-CoV-2 Spike\n• Six sites of N-linked microheterogeneity of human ACE2 receptor are described\n• Molecular dynamics simulations of Spike and ACE2 show essential ro"}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T25","span":{"begin":39,"end":44},"obj":"NCBITaxon:10239"},{"id":"T26","span":{"begin":159,"end":169},"obj":"SP_7"},{"id":"T27","span":{"begin":223,"end":228},"obj":"SP_6;NCBITaxon:9606;PG_10"},{"id":"T28","span":{"begin":229,"end":233},"obj":"PG_10;PR:000003622"},{"id":"T29","span":{"begin":304,"end":308},"obj":"G_3;PG_10;PR:000003622"}],"text":"form therapeutic strategies to inhibit viral infection.\n\nGraphical Abstract\n\nHighlights\n• Site-specific N-linked microheterogeneity is defined at 22 sites of SARS-CoV-2 Spike\n• Six sites of N-linked microheterogeneity of human ACE2 receptor are described\n• Molecular dynamics simulations of Spike and ACE2 show essential ro"}